COMPANY PROFILE · UPDATED 01 AUG 2026

Sonoma Biotherapeutics

Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing…

sonomabio.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2020
Headcount: 94
Open roles: 0
Last raised: Grant · Sign in to view

LEADERSHIP

Founders & key people

Fred Ramsdell

American immunologist

UC San DiegoUCLA

Jeffrey Bluestone

Immunologist, researcher

Sonoma BiotherapeuticsParker Institute for Cancer ImmunotherapyProvention BioUCSFUCSF Medical CenterImmune Tolerance NetworkCornell UniversityRutgers UniversityCook High SchoolJohn P. Stevens High School

Qizhi Tang

Founder at Sonoma Biotherapeutics

UCSFSonoma BiotherapeuticsQihan BiotechEncellineGenesisHuazhong University of Science and TechnologyUniversity of Illinois at ChicagoUniversity of ChicagoPeking Union Medical College

Alexander Rudensky

Founder at Vedanta Biosciences

Vedanta BiosciencesSonoma BiotherapeuticsAmgenSurface Oncology

OPEN ROLES

Hiring at Sonoma Biotherapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$365,300,000

Investors

Gv 8vcAlexandria Venture InvestmentsAlly Bridge GroupArch Venture PartnersArrowMark Colorado HoldingsAvidity PartnersCasdin CapitalDeep Track CapitalFidelityFrazier ManagementJDRF T1D FundJanus CapitalLifeforce CapitalLilly Asia VenturesLyell ImmunopharmaMilky Way VenturesMirae AssetNS InvestmentOctagon Capital AdvisorsOsage University Partners IIRegeneron PharmaceuticalsVertex Ventures HC

Funding rounds

Grant
$300KNov 3, 2025
Corporate Round
Regeneron Pharmaceuticals
$30MMar 27, 2023
Series B
Ally Bridge Group, Fidelity, NS Investment, JDRF T1D Fund, Lilly Asia Ventures, ArrowMark Colorado Holdings, 8VC, Vertex Ventures HC, Casdin Capital, GV, Avidity Partners, Lifeforce Capital, Arch Venture Partners, Janus Capital, Alexandria Venture Investments, Mirae Asset, Deep Track Capital, Osage University Partners II, Frazier Management, Octagon Capital Advisors
$265MAug 3, 2021
Series A
Arch Venture Partners, 8VC, Lilly Asia Ventures, Lyell Immunopharma, JDRF T1D Fund, Alexandria Venture Investments, Lifeforce Capital, Octagon Capital Advisors
$30MSep 29, 2020
Series A
Lyell Immunopharma, 8VC, Milky Way Ventures, Arch Venture Partners
$40MFeb 5, 2020

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Gv 8vc

Industries

Medical Organizations Biotechnology Companies

Collections

Has Woman Founder

LOCATIONS

Where they work

Sonoma Biotherapeutics Headquarters Location

400 E Jamie Ct suite 202, South San Francisco, CA, 94080

Loading map…